Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOMAGE spironolactone biomarker trial for heart failure prevention
2015-000413-48Phase 2Terminated
- Sponsor
- ACS Biomarker
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of spironolactone in heart failure (HF), sponsored by ACS Biomarker. Primary endpoint: Change in PIIINP. Started May 2015; status: terminated.
02
Drugs
spironolactone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2015-000413-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000413-48.